| Product dosage: 15mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.96 | $57.52 (0%) | 🛒 Add to cart |
| 90 | $0.84 | $86.27 $75.68 (12%) | 🛒 Add to cart |
| 120 | $0.78 | $115.03 $93.84 (18%) | 🛒 Add to cart |
| 180 | $0.72 | $172.55 $130.17 (25%) | 🛒 Add to cart |
| 240 | $0.70 | $230.06 $167.50 (27%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $345.09 $241.16 (30%) | 🛒 Add to cart |
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.47 (0%) | 🛒 Add to cart |
| 90 | $0.77 | $78.71 $69.62 (12%) | 🛒 Add to cart |
| 120 | $0.72 | $104.94 $86.78 (17%) | 🛒 Add to cart |
| 180 | $0.66 | $157.41 $119.07 (24%) | 🛒 Add to cart |
| 270 | $0.63 | $236.12 $170.53 (28%) | 🛒 Add to cart |
| 360 | $0.61
Best per pill | $314.82 $218.96 (30%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
actos
Pioglitazone, marketed under the brand name Actos among others, is a prescription medication belonging to the thiazolidinedione (TZD) class of antidiabetic agents. It’s primarily used in the management of type 2 diabetes mellitus to improve glycemic control. Unlike insulin secretagogues, its mechanism is distinct, functioning as an insulin sensitizer by activating peroxisome proliferator-activated receptor gamma (PPAR-γ) in adipose tissue, muscle, and liver. This monograph will dissect its clinical profile, from molecular action to real-world application, based on current evidence and extensive clinical experience.
Accupril: Effective Blood Pressure Control and Heart Failure Management - Evidence-Based Review
Accupril is the brand name for quinapril hydrochloride, an angiotensin-converting enzyme (ACE) inhibitor prescribed primarily for the management of hypertension and as adjunctive therapy in heart failure. This pharmaceutical agent works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing systemic vascular resistance. Unlike many dietary supplements, Accupril represents a well-established prescription medication with decades of clinical use and extensive research supporting its efficacy and safety profile across diverse patient populations.
aceon
Perindopril erbumine, marketed under the brand name Aceon, represents a significant advancement in the angiotensin-converting enzyme (ACE) inhibitor class. This medication has become a cornerstone in managing hypertension and reducing cardiovascular risk, particularly following myocardial infarction. Unlike many dietary supplements, Aceon undergoes rigorous pharmaceutical testing and standardization, making its dosing predictable and its effects well-characterized in clinical literature. Its mechanism—primarily through inhibition of angiotensin I to angiotensin II conversion—creates a cascade of hemodynamic benefits that we’ll explore in depth.
Amaryl: Effective Glycemic Control for Type 2 Diabetes - Evidence-Based Review
Let me walk you through my experience with Amaryl over the years - not the polished pharmaceutical brochure version, but what actually happens in clinical practice. When I first started prescribing glimepiride back in the late 90s, we were all still figuring out how this second-generation sulfonylurea would really perform outside the controlled trial environment. Product Description: Amaryl (glimepiride) is an oral antidiabetic medication belonging to the sulfonylurea class, specifically indicated for the management of type 2 diabetes mellitus.
artvigil
Artvigil represents a significant advancement in the wakefulness-promoting agent category, specifically as a generic version of armodafinil, the R-enantiomer of modafinil. Unlike traditional stimulants that broadly increase catecholamine release, it offers a more targeted mechanism with a distinct side effect profile. In my neurology practice, we’ve moved beyond simply labeling this as a “smart drug” and now appreciate its nuanced role in managing pathological sleepiness. Artvigil: Enhanced Wakefulness for Sleep Disorders - Evidence-Based Review 1.
atacand
Candesartan cilexetil, marketed under the brand name Atacand, represents a critical advancement in the angiotensin II receptor blocker (ARB) class, specifically engineered to selectively block the binding of angiotensin II to the AT1 receptor found in many tissues. This mechanism disrupts the renin-angiotensin-aldosterone system (RAAS), a key regulator of blood pressure and fluid balance. For clinicians managing hypertension and heart failure, Atacand offers a well-tolerated option with a lower incidence of cough compared to ACE inhibitors, making it particularly valuable for patients who develop that troublesome side effect.
Atorlip 10: Effective LDL Cholesterol Reduction for Cardiovascular Risk Management - Evidence-Based Review
Before we get to the formal structure, let me give you the real story behind Atorlip 10. I’ve been managing cardiovascular risk in my clinic for nearly two decades, and when we first started seeing generic atorvastatin formulations like Atorlip 10 hit the market around 2010, honestly, our entire cardiology department was divided. Dr. Chen in our practice was adamant we stick with brand-name Lipitor, arguing consistency in manufacturing mattered more than cost savings, while I had patients like 68-year-old Robert M.
avapro
Irbesartan, marketed under the brand name Avapro, represents a significant advancement in the angiotensin II receptor blocker (ARB) class of pharmaceuticals. Initially developed by Sanofi, this selective antagonist specifically targets the AT1 receptor subtype, demonstrating high affinity and insurmountable antagonism. The drug’s molecular structure—a biphenyl tetrazole derivative—confers unique pharmacokinetic properties that differentiate it from earlier ARBs like losartan. What’s particularly interesting is how its dual hepatic and renal excretion pathway makes it suitable for patients with varying degrees of hepatic impairment, something we’ve found clinically relevant when managing complex hypertension cases.
benicar
Benicar is the brand name for olmesartan medoxomil, an angiotensin II receptor blocker (ARB) medication used primarily for the management of hypertension. It works by selectively blocking the binding of angiotensin II to the AT1 receptors in vascular smooth muscle and the adrenal gland, leading to vasodilation and reduced aldosterone secretion. This prescription drug represents a critical tool in modern cardiovascular risk reduction strategies, particularly for patients who develop cough on ACE inhibitors.